Share on PinterestSputnik V shows promise in post-registration trials in Russia.Photo credit: Natalia Kolesnikova/AFP via Getty ImagesFirstly, scientists at the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, devised a vaccine that elicits a robust immune response, with no serious side effects in humans. The last few weeks also saw the development of a…
By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Sputnik V, Gamaleya National CenterTHE RUSSIAN DIRECT INVESTMENT FUND Latest coronavirus news as of 5 pm on 4 September Russia’s vaccine candidate produced antibody and T-cell responses in early-stage trial A preliminary trial of Russia’s coronavirus…
By Michael Le Page Denis Rebrikov says he will still move forward with gene-editing work to prevent heritable deafnessAndrey Rudakov/Bloomberg via Getty Russian biologist Denis Rebrikov has told New Scientist that he still plans to use CRISPR genome editing to prevent children inheriting deafness, despite a major international report out today saying it isn’t yet…
Your 30s and 40s are what some would consider the best years of your life. You’re no longer “figuring it out,” but you aren’t “old” by society’s ageist standards either. It should be a sweet spot—right? But despite the illusion of stability and security, it’s also common for anxiety and self-doubt to worsen during your
5 min read WHEN THE JUSTICE Department released a trove of Epstein-related files on January 30 and then pulled down thousands of pages after redaction failures exposed victims’ identifying information and explicit material, I felt a familiar gut-drop. Once again, the people with the least power were being asked to pay twice—first for the abuse
You don't have permission to access "http://www.medpagetoday.com/obgyn/hrt/119940" on this server. Reference #18.5bf4d517.1771491743.1e0de1 https://errors.edgesuite.net/18.5bf4d517.1771491743.1e0de1